journal article·2020-06-14Open access

Natural Epigenetic Modulators of Vitamin D Receptor

Giulia Apprato, Camilla Fiz, Isabella Fusano, Loredana Bergandi, Francesca Silvagno

Applied Sciences· Volume 10· Issue 12

Abstract

Vitamin D plays an important role in every tissue due to its differentiating properties and the control of calcium homeostasis. The reversion of the epigenetic repression of the vitamin D receptor (VDR) could lead to an increased sensitivity of the cells to the beneficial activity of the hormone and could be exploited in many vitamin D-resistant diseases. In this study we analyzed the effects of three natural epigenetic modulators: sulforaphane, curcumin, and the products of the fermentative activity of probiotics. Sulforaphane and curcumin are inhibitors of the DNA methyltransferases (DNMT) and of the histone deacetylases (HDAC); it has been demonstrated that sulforaphane and curcumin increase VDR expression in intestinal epithelial cells and in a human liver cancer cell line, respectively. The anti-inflammatory properties associated with the probiotic administration in vivo can be linked to the increased activity of intestinal VDR. Butyrate, an inhibitor of HDAC and a known modulator of VDR expression, is the candidate byproduct of fermentation by gut microbiome that could mediate the enhanced expression of VDR triggered by probiotics in vivo. Many other natural compounds wait to be investigated and recognized as epigenetic modulators of VDR, thus opening promising therapeutic avenues for many diseases by natural means.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Epigenetics and DNA Methylation · Vitamin D Research Studies · Adenosine and Purinergic Signaling

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Oncology, University of Torino, 10126 Turin, Italy

Department of Food, Environmental and Nutritional Sciences, University of Milan, 20133 Milan, Italy

References (100+)

Show source-provided references
1. Epigenetic impact of dietary polyphenols in cancer chemoprevention: Lifelong remodeling of our epigenomes10.1016/j.phrs.2012.03.007 ↗
2. Epigenetic changes induced by curcumin and other natural compounds10.1007/s12263-011-0222-1 ↗
3. Haroyan, A., Mukuchyan, V., Mkrtchyan, N., Minasyan, N., Gasparyan, S., Sargsyan, A., Narimanyan, M., and Hovhannisyan, A. (2018). Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: A comparative, randomized, double-blind, placebo-controlled study. BMC Complement. Altern. Med., 18.10.1186/s12906-017-2062-z ↗
4. Curcumin supplementation improves vascular endothelial function in healthy middle-aged and older adults by increasing nitric oxide bioavailability and reducing oxidative stress
5. A Novel Highly Bioavailable Curcumin Formulation Improves Symptoms and Diagnostic Indicators in Rheumatoid Arthritis Patients: A Randomized, Double-Blind, Placebo-Controlled, Two-Dose, Three-Arm, and Parallel-Group Study10.1089/jmf.2017.3930 ↗
6. Efficacy and Safety of Curcumin in Treatment of Intestinal Adenomas in Patients with Familial Adenomatous Polyposis10.1053/j.gastro.2018.05.031 ↗
7. A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (LipocurcTM) in patients with locally advanced or metastatic cancer10.1007/s00280-018-3654-0 ↗
8. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer10.4161/cbt.9.1.10392 ↗
9. Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial10.1016/j.phrs.2018.03.013 ↗
10. The effects of curcumin supplementation on high-sensitivity C-reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial10.1002/ptr.6328 ↗
11. Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial10.1055/s-0043-100019 ↗
12. Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial10.1016/j.jagp.2017.10.010 ↗
13. Curcumin and cognition: A randomised, placebo-controlled, double-blind study of community-dwelling older adults10.1017/S0007114516001203 ↗
14. Sulforaphane improves the bronchoprotective response in asthmatics through Nrf2-mediated gene pathways10.1186/s12931-015-0253-z ↗
15. Sulforaphane-rich broccoli sprout extract improves hepatic abnormalities in male subjects10.3748/wjg.v21.i43.12457 ↗
16. Prevention of Carcinogen-Induced Oral Cancer by Sulforaphane10.1158/1940-6207.CAPR-15-0290 ↗
17. A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer10.1007/s10637-014-0189-z ↗
18. Diet rich in high glucoraphanin broccoli reduces plasma LDL cholesterol: Evidence from randomised controlled trials10.1002/mnfr.201400863 ↗
19. Effect of broccoli sprouts on insulin resistance in type 2 diabetic patients: A randomized double-blind clinical trial10.3109/09637486.2012.665043 ↗
20. Genes, genetics, and epigenetics: A correspondence10.1126/science.293.5532.1103 ↗
21. Epigenetics: Definition, Mechanisms and Clinical Perspective10.1055/s-0029-1237423 ↗
22. Chromatin structure: A repeating unit of histones and DNA
23. Many roads to maturity: MicroRNA biogenesis pathways and their regulation10.1038/ncb0309-228 ↗
24. Histones and histone modifications10.1016/j.cub.2004.07.007 ↗
25. DNA methylation, chromatin inheritance, and cancer10.1038/sj.onc.1204339 ↗
26. Histone lysine methylation: A signature for chromatin function10.1016/j.tig.2003.09.007 ↗
27. Epigenetics and human disease: Translating basic biology into clinical applications10.1503/cmaj.050774 ↗
28. DNA methylation and chromatin—Unraveling the tangled web10.1038/sj.onc.1205609 ↗
29. Gene activation and gene silencing: A subtle equilibrium10.1089/1536230041372454 ↗
30. Heterochromatin: Silence is golden10.1016/j.cub.2003.11.006 ↗
31. Chromatin dynamics at DNA replication, transcription and repair10.1111/j.1432-1033.2004.04162.x ↗
32. Cancer Epigenetics: From Mechanism to Therapy10.1016/j.cell.2012.06.013 ↗
33. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer10.1038/ng1531 ↗
34. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia10.1038/nature10509 ↗
35. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: A randomised, open-label, phase III study10.1016/S1470-2045(09)70003-8 ↗
36. New Ways to Use DNA Methyltransferase Inhibitors for the Treatment of Myelodysplastic Syndrome10.1182/asheducation-2011.1.550 ↗
37. Molecular Mechanisms of Vitamin D Action10.1007/s00223-012-9619-0 ↗
38. Primary Vitamin D Target Genes of Human Monocytes10.3389/fphys.2019.00194 ↗
39. Genomic Determinants of Vitamin D-Regulated Gene Expression10.1016/bs.vh.2015.10.011 ↗
40. Vitamin D: A Micronutrient Regulating Genes10.2174/1381612825666190705193227 ↗
41. Tuoresmäki, P., Väisänen, S., Neme, A., Heikkinen, S., and Carlberg, C. (2014). Patterns of genome-wide VDR locations. PLoS ONE, 9.10.1371/journal.pone.0096105 ↗
42. Molecular endocrinology of vitamin D on the epigenome level10.1016/j.mce.2017.03.016 ↗
43. Regulation of the vitamin D receptor gene by environment, genetics and epigenetics10.1016/j.gene.2015.02.024 ↗
44. Up-regulation of the vitamin D receptor in response to 1,25-dihydroxyvitamin D3 results from ligand-induced stabilization10.1016/S0021-9258(19)88668-4 ↗
45. Single nucleotide polymorphisms in the vitamin D pathway associating with circulating concentrations of vitamin D metabolites and non-skeletal health outcomes: Review of genetic association studies10.1016/j.jsbmb.2015.12.007 ↗
46. Vitamin D receptor protein expression in tumor tissue and prostate cancer progression10.1200/JCO.2010.30.9880 ↗
47. Tumor Expression of Vitamin D Receptor and Breast Cancer Histopathological Characteristics and Prognosis10.1158/1078-0432.CCR-16-0075 ↗
48. Expression of vitamin D receptor decreases during progression of pigmented skin lesions10.1016/j.humpath.2010.09.014 ↗
49. Nuclear vitamin D receptor expression is associated with improved survival in non-small cell lung cancer10.1016/j.jsbmb.2010.10.002 ↗
50. In vivo binding to and functional repression of the VDR gene promoter by SLUG in human breast cells10.1016/j.bbrc.2008.04.187 ↗
51. Constitutively active RAS signaling reduces 1,25 dihydroxyvitamin D-mediated gene transcription in intestinal epithelial cells by reducing vitamin D receptor expression10.1016/j.jsbmb.2017.01.008 ↗
52. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene10.1038/75985 ↗
53. Lopes, N., Sousa, B., Martins, D., Gomes, M., Vieira, D., Veronese, L.A., Milanezi, F., Paredes, J., Costa, J.L., and Schmitt, F. (2010). Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: A study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions. BMC Cancer, 10.10.1186/1471-2407-10-483 ↗
54. Increased expression of CYP24A1 correlates with advanced stages of prostate cancer and can cause resistance to vitamin D3-based therapies10.1096/fj.13-236109 ↗
55. Expression of VDR and CYP24A1 mRNA in human tumors10.1007/s00280-005-0059-7 ↗
56. Vitamin D Signaling, Infectious Diseases, and Regulation of Innate Immunity10.1128/IAI.00353-08 ↗
57. The protective effect of estrogen against chemically induced murine colon carcinogenesis is associated with decreased CpG island methylation and increased mRNA and protein expression of the colonic vitamin D receptor
58. DNA methylation-related vitamin D receptor insensitivity in breast cancer10.4161/cbt.10.1.11994 ↗
59. VDR hypermethylation and HIV-induced T cell loss10.1189/jlb.0812383 ↗
60. Bock, C., Walter, J., Paulsen, M., and Lengauer, T. (2007). CpG island mapping by epigenome prediction. PLoS Comput. Biol., 3.10.1371/journal.pcbi.0030110 ↗
61. Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines
62. Multifunctional Enhancers Regulate Mouse and Human Vitamin D Receptor Gene Transcription10.1210/me.2009-0140 ↗
63. Chromatin Modifications and Their Function10.1016/j.cell.2007.02.005 ↗
64. Differential chromatin marking of introns and expressed exons by H3K36me310.1038/ng.322 ↗
65. ChIP-seq analysis reveals distinct H3K27me3 profiles that correlate with transcriptional activity10.1093/nar/gkr416 ↗
66. (2018). O’Brien J, Hayder H, Zayed Y, Peng, C. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front. Endocrinol. (Lausanne), 9, 402.10.3389/fendo.2018.00402 ↗
67. VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells10.1016/j.jsbmb.2010.02.003 ↗
68. MicroRNA regulates human vitamin D receptor10.1002/ijc.24459 ↗
69. Genomic determinants of gene regulation by 1,25-dihydroxyvitamin D3 during osteoblast-lineage cell differentiation10.1074/jbc.M114.578104 ↗
70. The osteoblast to osteocyte transition: Epigenetic changes and response to the vitamin D3 hormone10.1210/me.2014-1091 ↗
71. Coregulator function: A key to understanding tissue specificity of selective receptor modulators10.1210/er.2003-0023 ↗
72. Genome-wide principles of gene regulation by the vitamin D receptor and its activating ligand10.1016/j.mce.2011.05.012 ↗
73. KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells10.1093/hmg/ddr399 ↗
74. Carlberg, C. (2019). Nutrigenomics of Vitamin D. Nutrients, 11.10.3390/nu11030676 ↗
75. Isothiocyanates as substrates for human glutathione transferases: Structure-activity studies10.1042/bj3110453 ↗
76. Reversible Conjugation of Isothiocyanates with Glutathione Catalyzed by Human Glutathione Transferases10.1006/bbrc.1995.1106 ↗
77. Human Genome Epidemiologic Reviews: The Beginning of Something HuGE10.1093/oxfordjournals.aje.a010117 ↗
78. Molecular basis for chemoprevention by sulforaphane: A comprehensive review10.1007/s00018-007-6484-5 ↗
79. Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes
80. Sulforaphane and its glutathione conjugate but not sulforaphane nitrile induce UDP-glucuronosyl transferase (UGT1A1) and glutathione transferase (GSTA1) in cultured cells10.1093/carcin/23.8.1399 ↗
81. Effect of isothiocyanates on nuclear accumulation of NF-kappaB, Nrf2, and thioredoxin in caco-2 cells10.1021/jf052717h ↗
82. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray
83. Total intracellular accumulation levels of dietary isothiocyanates determine their activity in elevation of cellular glutathione and induction of Phase 2 detoxification enzymes10.1093/carcin/22.12.1987 ↗
84. Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition10.1089/ars.2014.6097 ↗
85. Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice10.1096/fj.05-4785fje ↗
86. Sulforaphane treatment of autism spectrum disorder (ASD)10.1073/pnas.1416940111 ↗
87. Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes10.1126/scitranslmed.aah4477 ↗
88. The dietary histone deacetylase inhibitor sulforaphane induces human β-defensin-2 in intestinal epithelial cells10.1111/j.1365-2567.2008.02834.x ↗
89. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease10.1074/jbc.C109.071225 ↗
90. Curcumin: The Indian solid gold10.1007/978-0-387-46401-5_1 ↗
91. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]10.1074/jbc.270.42.24995 ↗
92. Jaksevicius, A., Carew, M., Mistry, C., Modjtahedi, H., and Opara, E. (2017). Inhibitory Effects of Culinary Herbs and Spices on the Growth of HCA-7 Colorectal Cancer Cells and Their COX-2 Expression. Nutrients, 9.10.3390/nu9101051 ↗
93. Effects of Curcumin on Tumour Necrosis Factor-alpha and Interleukin-6 in the Late Phase of Experimental Acute Pancreatitis10.1111/j.1439-0442.2006.00786.x ↗
94. Thioredoxin Reductase Is Irreversibly Modified by Curcumin: A Novel Molecular Mechanism for its Anticancer Activity10.1074/jbc.M414645200 ↗
95. Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: Relationship with drug levels
96. de L.P. Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats10.1006/phrs.2000.0724 ↗
97. Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer10.1158/1078-0432.CCR-08-0024 ↗
98. Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers10.1007/s00280-011-1673-1 ↗
99. Lopes-Rodrigues, V., Sou, E., and Vasconcelos, M.H. (2016). Curcumin as a Modulator of P-Glycoprotein in Cancer: Challenges and Perspectives. Pharmaceuticals (Basel), 9.10.3390/ph9040071 ↗
100. Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation10.1111/j.1745-7254.2005.00081.x ↗